CTRI/2023/03/050831
Not Yet Recruiting
N/A
Clinical Profile of children presenting with strabismus at a tertiary eye care hospital in South India
Dr Annesha Sonowal0 sites0 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Health Condition 1: H509- Unspecified strabismus
- Sponsor
- Dr Annesha Sonowal
- Status
- Not Yet Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children with strabismus in the age group 0\-18 yrs of age
Exclusion Criteria
- •Post squint surgery
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
TO KNOW THE CLINICAL PRESENTATION AND VARIOUS CAUSES OF DIFFICULTY IN BREATHING IN THE INFANTSCTRI/2021/04/032681Department of Pediatrics
Completed
N/A
Prospective clinical study in children with severe haemophilia A to investigate clinical efficacy, immunogenicity, pharmacokinetics, and safety of Human-cl rhFVIIISevere haemophilia AHaematological DisordersHaemophiliaISRCTN71212110Octapharma AG (Switzerland)60
Recruiting
N/A
A Comparative clinical outcome study of Children with Severe Pneumonia at KCMH and ASIAN PICU(PACCMAN)severe pneumonia in childrenTCTR20210929008/A100
Active, Not Recruiting
N/A
PROSPECTIVE CLINICAL STUDY IN CHILDREN WITH SEVERE HAEMOPHILIA A TO INVESTIGATE CLINICAL EFFICACY, IMMUNOGENICITY, PHARMACOKINETICS, AND SAFETY OF HUMAN-CL RHFVIIISevere Haemophilia AMedDRA version: 12.1Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)EUCTR2010-018644-14-ATOctapharma AG60
Active, Not Recruiting
N/A
PROSPECTIVE CLINICAL STUDY IN CHILDREN WITH SEVERE HAEMOPHILIA A TO INVESTIGATE CLINICAL EFFICACY, IMMUNOGENICITY, PHARMACOKINETICS, AND SAFETY OF HUMAN-CL RHFVIII - GENA-03Severe Haemophilia AEUCTR2010-018644-14-GBOctapharma AG60